natgillin/translations-raw huggingface dataset:
All these actions are important in themselves, but they are also interdependent and need to be implemented in parallel in order to achieve the best outcome.
Vsi ti ukrepi so pomembni sami po sebi, so pa tudi medsebojno odvisni in jih je treba izvajati vzporedno, da se doseže najboljši rezultat.
Making the EU a best practice region
Prizadevanje za to, da EU postane regija najboljše prakse
Although in the EU a wide range of surveillance programmes and activities across different sectors exist, gaps in surveillance remain.
Čeprav v EU obstaja cela vrsta programov nadzora in dejavnosti v različnih sektorjih, so še vedno prisotne vrzeli v nadzoru.
Only a multidisciplinary effort can provide an adequate response.
Ustrezen odziv lahko zagotovijo samo multidisciplinarna prizadevanja.
Better implementation of EU rules
Boljše izvajanje predpisov EU
It will create more synergies and coherence between different policies according to the One Health approach.
Ustvaril bo več sinergij in skladnosti med različnimi politikami v skladu s pristopom „eno zdravje".
The EU is nevertheless in a strong position to act given its high degree of economic development, and commitment to a high level of human health protection.
Kljub temu pa je EU v dobrem položaju, da ukrepa, glede na svojo visoko stopnjo gospodarskega razvoja in zavezo visoki ravni varovanja zdravja ljudi.
According to the World Health Organization (WHO), AMR has already reached alarming levels in many parts of the world.
Po podatkih Svetovne zdravstvene organizacije (SZO) je že dosegla zaskrbljujoče ravni v mnogih delih sveta.
In total 421 responses were received from citizens and 163 from administrations, associations and other organisations.
Skupaj je bilo prejetih 421 odgovorov državljanov in 163 odgovorov uprav, združenj in drugih organizacij.
Recent developments and way forward
Najnovejši dosežki in pot naprej
To obtain the desired effect, it will be important to closely monitor the effectiveness and performance of certain key actions under this action plan at regular intervals and to modify them if necessary.
Za doseganje želenega učinka bo pomembno tesno spremljati učinkovitost in uspešnost nekaterih ključnih ukrepov iz tega akcijskega načrta v rednih časovnih presledkih in jih po potrebi spremeniti.
Benefit from the best evidence-based analysis and data
Koristi najboljše analize in podatkov na podlagi dokazov
encourage Member States to explore results and recommendations of EU research projects on new economic business models;
spodbujala države članice, naj raziščejo rezultate in priporočila raziskovalnih projektov EU o novih ekonomskih poslovnih modelih;
The EU and its Member States are part of an increasingly interconnected world characterised by an intensive exchange of people and commodities where policies implemented in one region can have significant impacts elsewhere.
EU in njene države članice so del medsebojno čedalje bolj povezanega sveta, za katerega sta značilna intenzivna izmenjava ljudi in blaga in kjer imajo lahko politike, ki se izvajajo v eni regiji, bistven vpliv drugod.
Over time, this makes antimicrobials less effective and ultimately useless.
Sčasoma postanejo antimikrobiki manj učinkoviti in na koncu tudi neuporabni.
It consisted of two separate online questionnaires: one for citizens and one for administrations, associations and other organisations.
Vključevalo je dva ločena spletna vprašalnika: enega za državljane in drugega za uprave, združenja in druge organizacije.
At the same time, the discovery, development, manufacture and marketing of new antimicrobials has significantly slowed down in the past 20 years.
Hkrati pa so se odkrivanje, razvoj, proizvodnja in trženje novih antimikrobikov v zadnjih 20 letih bistveno upočasnili.
It is estimated to be responsible for 25,000 deaths per year in the EU alone and 700,000 deaths per year globally.
Po ocenah naj bi zaradi nje vsako leto samo v EU umrlo 25 000, po vsem svetu pa kar 700 000 ljudi.
The new plan contains concrete actions with EU added value that the Commission will develop and strengthen as appropriate in the coming years.
Nov načrt vsebuje konkretne ukrepe z dodano vrednostjo EU, ki jih bo Komisija po potrebi razvila in okrepila v prihodnjih letih.
In the classic business model, pharmaceutical companies recuperate research and development investments selling large volumes of their medicinal products.
V klasičnem poslovnem modelu farmacevtska podjetja povrnejo naložbe v raziskave in razvoj s prodajo velikih količin svojih zdravil.
Develop new economic models and incentives
Razvoj novih gospodarskih modelov in spodbud
Many international initiatives have been launched during the last few years that would benefit from stronger collaboration in order to increase their impact, as expressed by the G739 and G20 Health Ministers.
V zadnjih nekaj letih so se začele izvajati številne mednarodne pobude, ki bodo izkoristile tesnejše sodelovanje za povečanje svojega vpliva, kot so jih izrazili ministri za zdravje skupin G739 in G20.
In addition, immunisation through vaccination is a cost-effective public health intervention with proven economic benefits.
Poleg tega je imunizacija s cepljenjem stroškovno učinkovit javnozdravstveni ukrep z dokazanimi gospodarskimi koristmi.
Historical data show a low success rate: only 1 out of 16 antibiotics from early-stage research reaches clinical application for patients.
Pretekli podatki kažejo nizko raven uspeha: samo eden od 16 antibiotikov iz zgodnje faze raziskave doseže klinično uporabo pri pacientih.
Since 1999, the Commission has invested over EUR 1.3 billion in AMR research, making Europe a leader in this domain.
Komisija je od leta 1999 vložila več kot 1,3 milijarde EUR v raziskave o odpornosti proti antimikrobikom, s čimer je Evropa prevzela vodilni položaj na tem področju.
improve global coordination of research activities by promoting dialogue and collaboration between international research initiatives;
izboljšala svetovno usklajevanje raziskovalnih dejavnosti s spodbujanjem dialoga in sodelovanja med mednarodnimi raziskovalnimi pobudami;
The Commission - with the help of EU agencies - will continue to support these countries through visits, best practice exchanges and capacity building.
Komisija bo ob pomoči agencij EU še naprej podpirala te države z obiski, izmenjavo najboljše prakse in gradnjo zmogljivosti.
This should be boosted even further to decrease the use of antimicrobials in those sectors.
To bi bilo treba spodbujati še bolj, da bi se raba antimikrobikov v teh sektorjih še zmanjšala.
Only sustained ambition, continued commitment and concerted action can turn the tide and diminish this global threat.
Samo trajnostna prizadevanja, trajne zaveze in usklajeno ukrepanje lahko pripeljejo do preobrata in zmanjšajo to globalno nevarnost.
The evaluation of the 2011 EU action plan recognised the positive effects of EU interventions at global level.
Ocena akcijskega načrta EU iz leta 2011 potrjuje pozitivne učinke ukrepov EU na svetovni ravni.
Overall, the replies submitted confirm the strong support for a new One Health action plan and the importance of a comprehensive approach.
Na splošno poslani odgovori potrjujejo močno podporo novemu akcijskemu načrtu „eno zdravje" in pomen celovitega pristopa.
support the establishment of a virtual research institute under JPIAMR;
podprla ustanovitev virtualnega raziskovalnega instituta v okviru programa JPIAMR;
making the EU a best practice region: as the evaluation of the 2011 action plan highlighted, this will require better evidence, better coordination and surveillance, and better control measures.
prizadevanje za to, da EU postane regija najboljše prakse: kot je poudarjeno v akcijskem načrtu iz leta 2011, bodo za to potrebni boljši dokazi, boljše usklajevanje in nadzor ter boljši kontrolni ukrepi.
Resistant bacteria and infectious diseases do not respect borders.
Odporne bakterije in nalezljive bolezni se ne menijo za meje.
A stronger EU global presence
Močnejša prisotnost EU v svetu
The World Bank has warned that, by 2050, drug-resistant infections could cause global economic damage on a par with the 2008 financial crisis.
Svetovna banka je opozorila, da bi okužbe, odporne proti zdravilom, do leta 2050 lahko povzročile svetovno gospodarsko škodo, ki bi se lahko merila s finančno krizo leta 2008.
Using different funding instruments and partnerships under its current and future framework programmes for research and innovation, the Commission will focus on the following actions.
Komisija se bo z uporabo različnih instrumentov financiranja in partnerstev v okviru svojih sedanjih in prihodnjih okvirnih programov za raziskave in inovacije osredotočila na naslednje ukrepe.
Specific actions to improve the knowledge base are considered in section 3.
Oddelek 3 obravnava posebne ukrepe za izboljšanje baze znanja.
The EU has gained valuable expertise and experience in relation to AMR, while some of its trading partners have taken different approaches and chosen different priorities in this regard.
EU je pridobila dragoceno strokovno znanje in izkušnje v zvezi z odpornostjo proti antimikrobikom, medtem ko so nekateri njeni trgovinski partnerji sprejeli drugačne pristope in izbrali druge prednostne naloge v zvezi s tem.
Other actions focus on identified gaps in the EU response so far that requires new activities, the discovery of new knowledge and the creation of new partnerships.
Drugi ukrepi so usmerjeni v prepoznavanje vrzeli v dosedanjem odzivanju EU, kar zahteva nove dejavnosti, iskanje novega znanja in oblikovanje novih partnerstev.
This process can be supported through dialogue, aid and cooperation activities, taking account of partner countries' individual policy priorities to strengthen health systems and implement the sustainable development goals, in particular the third goal on good health and well-being.
Ta proces bi lahko podprli z dialogom, pomočjo in dejavnostmi sodelovanja ob upoštevanju posameznih prednostnih nalog politike partnerskih držav za okrepitev zdravstvenih sistemov in izvajanje ciljev trajnostnega razvoja, zlasti tretjega cilja za dobro zdravje in dobro počutje.
In order to tackle this situation, the Commission will concentrate on key areas with the highest added value for Member States, while respecting the limits of EU competence and bearing in mind that Member States remain primarily responsible for the definition of their health policies.
Da bi se Komisija spoprijela s tem stanjem, se bo osredotočila na ključna področja z najvišjo dodano vrednostjo za države članice, obenem pa spoštovala omejitve pristojnosti EU in upoštevala, da države članice ostajajo v prvi vrsti odgovorne za opredelitev svoje zdravstvene politike.
The action plan will strengthen collaboration and surveillance, will reduce data gaps and allow for the sharing of best practices within the EU.
Akcijski načrt bo okrepil sodelovanje in nadzor, zmanjšal vrzeli v podatkih in omogočil izmenjavo dobrih praks v EU.
Such mutation is then passed on conferring resistance.
Takšna mutacija se nato prenaša naprej in omogoča odpornost.
Developing a global research agenda
Razvoj globalnega raziskovalnega programa
The evaluation concluded that the 2011 action plan had clear EU added value, was a symbol of political commitment, stimulated action within the Member States and strengthened international cooperation.
V oceni je bilo ugotovljeno, da je imel akcijski načrt iz leta 2011 jasno dodano vrednost EU, da je bil simbol politične zaveze, da je spodbujal ukrepanje znotraj držav članic in okrepil mednarodno sodelovanje.
Despite great efforts made in the past years, including through public-private partnerships, there are not enough antimicrobials in the pipeline to meet expected needs.
Kljub velikim prizadevanjem v preteklih letih, med drugim tudi prek javno-zasebnih partnerstev, v pripravi ni dovolj antimikrobikov za pričakovane potrebe.
They are active substances of synthetic or natural origin which kill or inhibit the growth of microorganisms.
To so aktivne snovi sintetičnega ali naravnega izvora, ki ubijajo mikroorganizme ali zavirajo njihovo rast.
AMR is a consequence of natural selection and genetic mutation.
To je posledica naravnega izbora in genske mutacije.
This would be in line with the increasing trend of developing new therapies combined with a diagnostic.
To bi bilo v skladu z naraščajočim trendom razvoja novih oblik zdravljenja, kombiniranih z diagnostiko.
Developing new antimicrobials or alternative therapies requires significant and long-term investments.
Razvoj novih antimikrobikov ali alternativnih zdravljenj zahteva znatne in dolgoročne naložbe.
Technology today enables to collect and use data from the healthcare (hospitals, health centres, laboratories, etc.) and agri-food sectors but also from society in general (the internet of Things, social networks, etc.).
Tehnologija danes omogoča zbiranje in uporabo podatkov iz zdravstvenega varstva (bolnišnic, zdravstvenih domov, laboratorijev itd.) in agroživilskega sektorja, pa tudi družbe na splošno (internet stvari, socialna omrežja itd.).
Develop new preventive vaccines
Razvoj novih preventivnih cepiv
The Commission will continue to bring together all relevant EU scientific agencies - notably the European Food Safety Authority (EFSA), the European Medicines Agency (EMA), and the European Centre for Disease Prevention and Control (ECDC) - to jointly take appropriate actions.
Komisija bo še naprej povezovala vse ustrezne znanstvene agencije EU, zlasti Evropsko agencijo za varnost hrane (EFSA), Evropsko agencijo za zdravila (EMA) in Evropski center za preprečevanje in obvladovanje bolezni (ECDC), da bi skupaj sprejeli ustrezne ukrepe.
Political Declaration of the high-level meeting of the General Assembly on antimicrobial resistance.
Political Declaration of the high-level meeting of the General Assembly on antimicrobial resistance (Politična izjava s srečanja Generalne skupščine na visoki ravni o odpornosti proti antimikrobikom).
This new action plan builds on the 2011 action plan, its evaluation, the feedback on the roadmap and an open public consultation.
Ta novi akcijski načrt temelji na akcijskem načrtu iz leta 2011, njegovi oceni, povratnih informacijah o načrtu in odprtem javnem posvetovanju.
support increasing the knowledge base concerning the barriers that influence the wider use of vaccination in medical and veterinary practice.
podpirala povečanje baze znanja o ovirah, ki vplivajo na širšo uporabo cepljenja v medicinski in veterinarski praksi.
Combining these data makes it possible to detect disease outbreaks much earlier and helps to understand how infectious diseases are transmitted.
Združevanje teh podatkov omogoča veliko zgodnejše odkrivanje izbruhov bolezni in pomaga razumeti, kako se infekcijske bolezni prenašajo.
support Member States' national awareness-raising efforts with specific communication tools targeting key audiences and contribute to the annual European Antibiotic Awareness Day (EAAD).
podpirala nacionalna prizadevanja držav članic na področju ozaveščanja s posebnimi komunikacijskimi orodji, namenjenimi ključnim ciljnim občinstvom, ter prispevala k vsakoletnemu evropskemu dnevu ozaveščanja o antibiotikih (EAAD).
Vaccines already play an important role in preventing disease in farm animals and aquaculture.
Cepiva že imajo pomembno vlogo pri preprečevanju bolezni pri rejnih živalih in v akvakulturi.
[25: Special Eurobarometer 338 (April 2010), Special Eurobarometer 407 (November 2013) and Special Eurobarometer 445 (June 2016)]
[25: Posebna raziskava Eurobarometra 338 (april 2010), Posebna raziskava Eurobarometra 407 (november 2013) in Posebna raziskava Eurobarometra 445 (junij 2016).]
For example universal coverage by a pneumococcal vaccine could not only save many of the estimated 800,000 children who die each year of pneumonia, it would also reduce by an estimated 47% the use of antimicrobials, counteracting the development of AMR.
Na primer, splošna pokritost s pnevmokoknim cepivom bi lahko ne samo rešila številne od približno 800 000 otrok, ki vsako leto umrejo zaradi pljučnice, temveč bi za približno 47 % zmanjšala tudi rabo antimikrobikov, s čimer bi se zoperstavila razvoju odpornosti proti antimikrobikom.
In the EU alone it is estimated that AMR costs EUR 1.5 billion annually in healthcare costs and productivity losses4.
Ocenjeno je, da odpornost proti antimikrobikom samo v EU vsako leto povzroči 1,5 milijarde EUR stroškov zaradi potrebe po zdravstvenem varstvu in izgub produktivnosti4.
These achievements are now at risk mainly because of the excessive or inappropriate use of antimicrobials, which has led to the increasing emergence and spread of multi-resistant bacteria.
Te dosežke pa danes ogroža predvsem prekomerna ali neustrezna raba antimikrobikov, kar je pripeljalo do naraščajočega pojavljanja in širjenja multirezistentnih bakterij.
However, no single action will, in isolation, provide an adequate solution.
Vendar en sam ukrep, ločen od drugih, ne bo zagotovil ustrezne rešitve.
reduce the scope for falsified medicines by assisting Member States and stakeholders in the successful implementation of the safety features (unique identifier) that will appear by 2019 on the packaging of medicinal products for human use;
zmanjšala možnosti za lažna zdravila z zagotavljanjem pomoči državam članicam in zainteresiranim stranem pri uspešnem izvajanju varnostnih elementov (edinstvene oznake), ki se bodo do leta 2019 pojavili na ovojnini zdravil za uporabo v humani medicini;
Vaccines have proven to be crucial and very cost-effective in preventing the onset and spread of infectious diseases.
Cepiva so se dokazala kot ključna in zelo stroškovno učinkovita pri preprečevanju izbruha in širjenja infekcijskih bolezni.
The WHO, the OIE, the FAO, and the Codex Alimentarius are setting up systems and developing standards to monitor global effects.
Organizacije SZO, OIE, FAO in Codex Alimentarius vzpostavljajo sisteme in razvijajo standarde za spremljanje globalnih učinkov.
One Health: is a term used to describe a principle which recognises that human and animal health are interconnected, that diseases are transmitted from humans to animals and vice versa and must therefore be tackled in both.
Eno zdravje: je pojem, s katerim je opisano načelo, ki priznava, da je zdravje ljudi in živali medsebojno povezano, da se bolezni prenašajo z ljudi na živali in obratno in da je zato treba obravnavati oba vidika.
look for synergies with the UN Strategic Approach to International Chemicals Management's work on the emerging policy issue of pharmaceuticals in the environment;
iskala sinergije s strateškim pristopom ZN k delu na področju mednarodnega upravljanja kemikalij v zvezi s porajajočim se političnim vprašanjem glede farmacevtskih proizvodov v okolju;
Since penicillin was first discovered in 1928, life-saving antimicrobials have revolutionised our society and economy.
Antimikrobiki, ki rešujejo življenja, so po odkritju penicilina leta 1928 korenito spremenili našo družbo in gospodarstvo.
The AMR threat to public health and the social and economic burden it entails is even greater in developing countries.
Nevarnost, ki jo odpornost proti antimikrobikom pomeni javnemu zdravju, ter družbeno in gospodarsko breme, ki ga povzroča, sta še večja v državah v razvoju.
Novel diagnostics will also make it possible to recruit the right patients in clinical trials for new treatments, making the trials more efficient.
Nova diagnostika bo omogočila tudi iskanje ustreznih pacientov za klinična preskušanja novih zdravljenj, zaradi česar bodo ta preskušanja učinkovitejša.
Continued effort is necessary and is outlined below.
Potrebna so nadaljnja prizadevanja, kot je opisano v nadaljevanju.
Inaction is projected to cause millions of deaths globally: it has been estimated that AMR might cause more deaths than cancer by 2050.
Neukrepanje bi lahko povzročilo na milijone smrtnih primerov po vsem svetu: ocenjuje se, da bi zaradi odpornosti proti antimikrobikom lahko do leta 2050 umrlo več ljudi kot zaradi raka.
continue and strengthen ongoing collaboration within the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR), which includes the EU, the USA, Canada, and Norway;
nadaljevala in krepila obstoječe sodelovanje znotraj Čezatlantske delovne skupine za odpornost proti antimikrobikom (TATFAR), ki vključuje EU, ZDA, Kanado in Norveško;
encourage the EMA to review all available information on the benefits and risks of older antimicrobial agents and consider whether any changes to their approved uses in the Member States are required.
spodbujala agencijo EMA, naj pregleda vse razpoložljive informacije o koristih in tveganjih starejših antimikrobikov ter preuči, ali je treba njihovo odobreno rabo v državah članicah kakor koli spremeniti.
help to address patient safety in hospital environments by supporting good practices in infection prevention and control;
pomagala pri obravnavi varnosti pacientov v bolnišničnem okolju s podpiranjem dobrih praks pri preprečevanju in obvladovanju okužb;
AMR is a serious challenge, in the EU and globally.
Odpornost proti antimikrobikom predstavlja resen izziv tako v EU kot po vsem svetu.
Actions against AMR cannot succeed without the sustained involvement of stakeholders, including industry, civil society, academia, and non-governmental experts but also the European Economic and Social Committee (EESC), throughout policy development and implementation.
Ukrepi zoper odpornost proti antimikrobikom ne morejo biti uspešni brez stalne vključenosti zainteresiranih strani, med drugim industrije, civilne družbe, univerz in nevladnih strokovnjakov, in Evropskega ekonomsko-socialnega odbora (EESO) v celoten proces oblikovanja in izvajanja politike.
The synopsis report accompanying this Communication provides an overview of the contributions received and how they have been taken into account in defining concrete actions.
Zbirno poročilo, priloženo temu sporočilu, vsebuje pregled prejetih prispevkov in opisuje, kako so se upoštevali pri opredelitvi določenih ukrepov.
Antimicrobial resistance (AMR): is the ability of microorganisms, such as bacteria, to become increasingly resistant to an antimicrobial to which they were previously susceptible.
Odpornost proti antimikrobikom: je sposobnost mikroorganizmov, kot so bakterije, da postanejo čedalje odpornejši proti nekemu antimikrobiku, na katerega so bili prej občutljivi.
The Commission invites the European Parliament and the Council to endorse this One Health action plan and calls on Member States and all those involved to ensure that measures to combat AMR are swiftly implemented.
Komisija poziva Evropski parlament in Svet, naj potrdita ta akcijski načrt „eno zdravje", države članice in vse vključene strani pa poziva, naj zagotovijo, da se bodo ukrepi za boj zoper odpornost proti antimikrobikom hitro izvajali.
As requested by the Member States, the Council conclusions of 17 June 2016 call for a new and comprehensive EU action plan on AMR based on the One Health approach.
V skladu z zahtevami držav članic sklepi Sveta z dne 17. junija 2016 pozivajo k sprejetju novega in celovitega akcijskega načrta EU o odpornosti proti antimikrobikom, ki temelji na pristopu „eno zdravje".
The systematic inclusion of AMR-related provisions is now a current practice for the Commission in all new FTAs.
Sistematično vključevanje določb o odpornosti proti antimikrobikom je postalo sedanja praksa Komisije v vseh novih SPT.
These indicators will be developed with the support of the EU scientific agencies (see point 2.1) and will enable Member States to assess, in a clear and simple way, the progress made in the implementation of their national One Health action plans on AMR.
Ti kazalniki se bodo razvili ob podpori znanstvenih agencij EU (glej točko 2.1) in bodo državam članicam omogočili, da na jasen in preprost način ocenijo napredek pri izvajanju svojih nacionalnih akcijskih načrtov o odpornosti proti antimikrobikom v okviru pobude „eno zdravje".